— Know what they know.
Not Investment Advice

SRBCF OTC

Sirona Biochem Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -57.9% 3Y: -97.1% 5Y: -90.4%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $1.6M mcap · 245M float · 0.0000% daily turnover · Short 7% of daily vol

Cash Flow Trends

Operating Cash Flow
-$2M +19.3% ▲
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$2M +19.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$150K +142.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$5M-$4M-$2M-$4M-$3M
Depreciation & Amort.-$86K$10K$9K$9K$10K
Stock-Based Comp.$1M$2M$331K$1M$31K
Change in Working Capital$455$393K-$198K-$295K$553K
Other Non-Cash Items$25K$2K$0$196K$193K
Operating Cash Flow-$4M-$2M-$2M-$2M-$2M
— Investing Activities —
Capital Expenditures$0-$47K$0$0$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow$0-$47K$0$0$0
— Financing Activities —
Net Debt Issuance-$41K-$133K-$308K-$338K$2M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$4M$87K$2M$2M$52K
Financing Cash Flow$7M-$46K$1M$2M$2M
Net Change in Cash$3M-$2M-$758K-$356K$150K
Cash End of Period$4M$2M$778K$422K$571K
Free Cash Flow-$4M-$2M-$2M-$2M-$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms